---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-025357"
form_type: "8-K"
ticker: null
cik: "0001822691"
company_name: "GreenLight Biosciences Holdings, PBC"
filed_at: "2023-05-31T23:59:59+00:00"
generated_at: "2026-06-14T10:46:21.229102+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# GreenLight Biosciences cuts 51% of workforce, expects $6-8M restructuring charge

## Summary
- Board authorized restructuring plan to extend cash runway; workforce reduced by approximately 51%.
- Pre-tax restructuring charge of $6 to $8 million expected in Q2 2023, primarily cash expenditures.
- Actions substantially complete by Q3 2023, subject to local law requirements.
- Reduction targets employees supporting programs without anticipated short-term value creation.

## SEC filing metadata
- accession: 0000950170-23-025357
- form_type: 8-K
- cik: 0001822691
- company_name: GreenLight Biosciences Holdings, PBC
- filed_at: 2023-05-31T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.05
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822691/000095017023025357/0000950170-23-025357-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822691/000095017023025357/grna-20230530.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-025357
- JSON: https://secwatch.observer/filing/0000950170-23-025357.json
- Plain text: https://secwatch.observer/filing/0000950170-23-025357.txt

## Key facts
- Restructurings & Charges
  GreenLight Biosciences Holdings, PBC announced a restructuring with charges of approximately $6 to $8 million (approximately 51%).
  - Type: restructuring
  - Charge: approximately $6 to $8 million
  - Headcount: approximately 51%
  source text: As a result of the Plan, the Company expects to incur a pre-tax restructuring charge in the second quarter of 2023 of approximately $6 to $8 million, consisting primarily of cash expenditures which are expected to consist of employee severance payments, employee transition, other restructuring related costs and expenses, and impacted contract commitments.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1822691/000095017023025357/0000950170-23-025357-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.